Biomarkers in Acute Mesenteric Ischemia: A Systematic Review of Diagnostic Performance and Injury-Related Signals
Authors:
- Zelimkhan BerikkhanovZBZelimkhan Berikkhanov
- Zakhar AkulovZAZakhar Akulov
- Ekaterina KlimovaEKEkaterina Klimova
- David PogosyanDPDavid Pogosyan
- Evgeniy TarabrinETEvgeniy Tarabrin
- Alexey ShestakovASAlexey Shestakov
- Aleksey KotelnikovAKAleksey Kotelnikov
- Andrey NikolaevANAndrey Nikolaev
- Vadim RazumovskyVRVadim Razumovsky
- Milena IvanovaMIMilena Ivanova
- Mehrshad EbrahimnezhadMEMehrshad Ebrahimnezhad
- Sara NourmahalSNSara Nourmahal
Open Access
- 15 October 2026
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3360
Abstract
Background/Objectives: We examined nine biomarkers for acute mesenteric ischemia (AMI) detection, necrosis and postoperative prediction. Methods: PubMed/MEDLINE, the Cochrane Library and indexed citation links were searched on 10 October 2026 without a lower publication-year limit. PubMed and citation searches used an October 2026 publication cutoff. English- and Russian-language clinical reports with at least 10 participants were eligible. Narrative synthesis used QUADAS-2 and diagnostic GRADE. Results: Twenty-nine primary reports were included, with reported cohorts of 18–1479 participants. Cohort overlap and varying tested denominators precluded an unduplicated participant total. Among 28 diagnostic reports, 22 had high index-test risk and 25 had high flow/timing risk. Certainty was very low for eight markers. I-FABP, α-GST and citrulline findings depended on population, assay and timing. D-dimer, lactate, procalcitonin and ischemia-modified albumin lacked intestinal specificity. Urinary I-FABP estimates were imprecise. SM22 supplied association data without diagnostic-performance estimates. Conclusions: No evaluated marker supports reliable stand-alone exclusion of AMI or determination of bowel viability. Complementary panels require prospective validation. The injury diagrams are unvalidated research models.Keywords
Funding Information
- Ekaterina Klimova and David Pogosyan
This publication has 60 references indexed in Scilit:
- Efficiency of Using D Dimer and Lactic Acid as Biomarkers to Diagnose Acute Mesenteric Ischemia in Emergency Patients: A Systematic Review and Meta-AnalysisBratislava Medical Journal, 2025
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy StudiesJAMA, 2018
- Diagnostic accuracy of novel serological biomarkers to detect acute mesenteric ischemia: a systematic review and meta-analysisInternal and Emergency Medicine, 2017
- ESTES guidelines: acute mesenteric ischaemiaEuropean Journal of Trauma and Emergency Surgery, 2016
- Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosisSurgical Endoscopy, 2015
- Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemiaBritish Journal of Surgery, 2014
- The value of the serum I-FABP level for diagnosing acute mesenteric ischemiaSurgery Today, 2013
- Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?Intensive Care Medicine, 2011
- Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation studyJournal of Gastroenterology, 2011
- Systematic Review and Pooled Estimates for the Diagnostic Accuracy of Serological Markers for Intestinal IschemiaWorld Journal of Surgery, 2009